Italian Medicines Agency’s reform and time until pricing and reimbursement decisions: a time-to-event analysis

Key Points

• To assess the impact of the AIFA reform on the timing of pricing and reimbursement decisions for new medicines in Italy.
• Analyzed time-to-event data related to pricing and reimbursement negotiations
• Evaluated the effects of the AIFA reform on decision times
• Used statistical modeling to measure efficiency changes
• The reform led to faster pricing and reimbursement decisions in Italy
• Increased efficiency was observed following the consolidation of committees
• The findings suggest improvements in the health technology assessment process

Abstract